Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name SAR408701
Trade Name
Synonyms SAR-408701|Tusamitamab ravtansine
Drug Descriptions

SAR408701 is an anti-CEACAM5 antibody in conjugation with DM4, which may lead to specific toxicity towards CEACAM5-expressing tumor cells (Eu J Cancer Dec 2016, 69(Suppl 1):S14-S15).

DrugClasses CEACAM5 Antibody 7
CAS Registry Number 2254086-60-5
NCIT ID C117229


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Carboplatin + Pembrolizumab + Pemetrexed Disodium + SAR408701 Carboplatin Pembrolizumab Pemetrexed Disodium SAR408701 0 1
Carboplatin + Pembrolizumab + SAR408701 Carboplatin Pembrolizumab SAR408701 0 1
Cisplatin + Pembrolizumab + SAR408701 Cisplatin Pembrolizumab SAR408701 0 1
Cisplatin + Pemetrexed Disodium + SAR408701 Cisplatin Pemetrexed Disodium SAR408701 0 1
Diphenhydramine + SAR408701 Diphenhydramine SAR408701 0 0
Gemcitabine + SAR408701 Gemcitabine SAR408701 0 1
Pembrolizumab + Ramucirumab + SAR408701 Pembrolizumab Ramucirumab SAR408701 0 1
Pembrolizumab + SAR408701 Pembrolizumab SAR408701 0 1
Ramucirumab + SAR408701 Ramucirumab SAR408701 0 2
SAR408701 SAR408701 0 6

Additional content available in CKB BOOST